DK0540135T3 - Attenueret mæslingevaccine-virusstamme indeholdende specifik nuklotidsekvens og en fremgangsmåde til dens absolutte identif - Google Patents

Attenueret mæslingevaccine-virusstamme indeholdende specifik nuklotidsekvens og en fremgangsmåde til dens absolutte identif

Info

Publication number
DK0540135T3
DK0540135T3 DK92302004T DK92302004T DK0540135T3 DK 0540135 T3 DK0540135 T3 DK 0540135T3 DK 92302004 T DK92302004 T DK 92302004T DK 92302004 T DK92302004 T DK 92302004T DK 0540135 T3 DK0540135 T3 DK 0540135T3
Authority
DK
Denmark
Prior art keywords
nucleotide sequence
specific nucleotide
containing specific
strain containing
virus strain
Prior art date
Application number
DK92302004T
Other languages
English (en)
Inventor
Keiko Sasaki
Takayuki Mori
Satoshi Makino
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Application granted granted Critical
Publication of DK0540135T3 publication Critical patent/DK0540135T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18421—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK92302004T 1991-10-14 1992-03-10 Attenueret mæslingevaccine-virusstamme indeholdende specifik nuklotidsekvens og en fremgangsmåde til dens absolutte identif DK0540135T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3293625A JP3045581B2 (ja) 1991-10-14 1991-10-14 麻疹ワクチンウイルス株同定方法

Publications (1)

Publication Number Publication Date
DK0540135T3 true DK0540135T3 (da) 2000-08-07

Family

ID=17797135

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92302004T DK0540135T3 (da) 1991-10-14 1992-03-10 Attenueret mæslingevaccine-virusstamme indeholdende specifik nuklotidsekvens og en fremgangsmåde til dens absolutte identif

Country Status (10)

Country Link
US (2) US5654136A (da)
EP (1) EP0540135B1 (da)
JP (1) JP3045581B2 (da)
KR (1) KR950012759B1 (da)
AT (1) ATE193726T1 (da)
DE (1) DE69231143T2 (da)
DK (1) DK0540135T3 (da)
ES (1) ES2148164T3 (da)
GR (1) GR3034278T3 (da)
PT (1) PT540135E (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0635056A1 (en) * 1992-04-08 1995-01-25 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Wild-type measles virus glycoproteins: vaccine and detection method therefor
US6638482B1 (en) * 1993-11-01 2003-10-28 Nanogen, Inc. Reconfigurable detection and analysis apparatus and method
EP0920449B1 (en) * 1996-07-31 2002-10-23 Claude P. Muller Morbillivirus-derived peptides
CN1232504A (zh) * 1996-09-27 1999-10-20 美国氰胺公司 在单链负义病毒目病毒内引起减毒的3'基因组启动子区和聚合酶基因中的突变
US6277380B1 (en) * 1997-06-04 2001-08-21 The Research Foundation For Microbial Diseases Of Osaka University Measles virus mutant antigen
CN1600852A (zh) * 1998-03-26 2005-03-30 惠氏控股有限公司 引起麻疹病毒或人呼吸道合胞病毒亚组b减毒的突变
AU781005B2 (en) * 1999-11-19 2005-04-28 Daiichi Sankyo Company, Limited Method for producing cell-fusion type morbillivirus mutant
JP3946045B2 (ja) 2000-01-31 2007-07-18 財団法人阪大微生物病研究会 弱毒生水痘ワクチンの品質管理方法
WO2001059125A1 (fr) * 2000-02-10 2001-08-16 The Kitasato Institute Procede d'elaboration de morbilli virus thermosensibles
EP1375670B1 (en) 2002-06-20 2013-06-12 Institut Pasteur Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions
EP1375512B1 (en) * 2002-06-20 2009-07-22 Institut Pasteur Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions
CA2432738A1 (en) 2003-02-26 2004-08-26 Philippe Despres New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
EP2420242A1 (en) 2010-08-20 2012-02-22 Lauer, Ulrich M. Oncolytic measles virus
CN104211769B (zh) * 2013-05-30 2018-08-03 中国科学院过程工程研究所 一种小分子抗体亲和肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617261A (en) * 1984-03-21 1986-10-14 Cetus Corporation Process for labeling nucleic acids and hybridization probes
JPS63307827A (ja) * 1987-06-08 1988-12-15 Kitasato Inst:The 安定化された生ウイルスワクチンおよびその製造法
AU7007491A (en) * 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses

Also Published As

Publication number Publication date
US5824777A (en) 1998-10-20
US5654136A (en) 1997-08-05
JP3045581B2 (ja) 2000-05-29
ES2148164T3 (es) 2000-10-16
EP0540135A3 (en) 1993-12-08
KR930008138A (ko) 1993-05-21
KR950012759B1 (ko) 1995-10-21
DE69231143T2 (de) 2000-10-19
PT540135E (pt) 2000-11-30
DE69231143D1 (de) 2000-07-13
ATE193726T1 (de) 2000-06-15
EP0540135A2 (en) 1993-05-05
GR3034278T3 (en) 2000-12-29
EP0540135B1 (en) 2000-06-07
JPH05103665A (ja) 1993-04-27

Similar Documents

Publication Publication Date Title
DK0540135T3 (da) Attenueret mæslingevaccine-virusstamme indeholdende specifik nuklotidsekvens og en fremgangsmåde til dens absolutte identif
DE69627698T2 (de) Eine in kaskaden verlaufende vervielfältigungsreaktion von nukleinsäuren
DE3888425T2 (de) Virale Expressionsinhibitoren.
NO904634L (no) Amplifikasjon av nukleinsyre ved anvendelse av ligerbare,haarnaalsprobe og transkripsjon.
DK0522880T3 (da) Gensekvenser som koder for flavonoid pathway enzymer og anvendelse
FI843529A0 (fi) Foerfarande foer detektering, identifiering och kvantitering av organismer och virus.
ATE172642T1 (de) Impfstoffe und verfahren zu ihrer herstellung
DK0500917T3 (da) Vacciner og fremgangsmåder baseret på rekombinante herpes simplex virusser.
ZA862334B (en) Process for amplifying,detecting and/or cloning nucleic acid sequences
DE59609841D1 (de) Verfahren zur Gattungs- und speziesspezifische Identifizierung von Legionellen
GR3021781T3 (en) Specific detection of mycobacterium tuberculosis
ZA925259B (en) Immobilization of nucleic acids
EP0438292A3 (en) Method of preparing primers for polymerase chain reaction and dna amplification using said primers
DK8789A (da) Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse
NO940658D0 (no) Nukleinsyre-polymerase-forökning
AU1521492A (en) Recombinant varicella-zoster virus and process for constructing same
DK76688D0 (da) Vaccine indeholdende f-proteinet fra aids-virus
DK232187A (da) Fremgangsmaade og apparat til detektion af virale dna og rna genomer i biologiske medier, navnlig i blodserum
DK82591D0 (da) Saar-stimuleret dna-sekvens fra solanum tuberosum og dens anvendelse
HK74595A (en) Specific nucleic-acid fragments of the human villin gene and their application to diagnostic ends
NO875058L (no) Oligonukleotidprober og fremgangsmÿte for detektering av nukleinsyrene i bakterier og andre levende organismer ved hybridisering.
FI893346A0 (fi) Icke-reverterande rna-virus.
DK98691D0 (da) Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf